Clinical Trial

Effects of Lurasidone on Left Ventricle Systolic Functions

Study acronym: Lurasidone
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 19, 2024 (before its estimated May 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of our study to learn if lurasidone molecule which is used on patients with schizophrenia or bipolar disorder has any cardiotoxic effect.
Trial Details
NCT Number NCT06695676
Lead Sponsor Aydin Adnan Menderes University
Conditions Lurasidone Cardiotoxicity, Schizophrenia Patients, Bipolar Disorders
Enrollment 62 participants
Start Date 2024-11
Primary Completion 2025-05-01 (estimated)
Study Completion 2025-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-19